Bacteria control how infectious they become, study findsApril 13, 2007COLUMBUS, Ohio - The results of a new study suggest that bacteria that cause diseases like bubonic plague and serious gastric illness can turn the genes that make them infectious on or off. Knowing how disease-causing bacteria, like Yersinia pestis and E. coli, do this may one day help scientists create drugs that control the expression of these genes, thereby making the bacteria harmless, said Vladimir Svetlov, a study co-author and a research associate in microbiology at Ohio State University. The findings appear in the April 13 issue of the journal Molecular Cell. Gene expression - the process of turning on, or activating, genes - is controlled by proteins called transcription factors. Every type of bacteria known to humankind contains the transcription factor NusG, which controls nearly all of a bacterium's gene expression. Without it, a microorganism will die.
"We think that NusG regulates nearly every gene in every form of bacteria," said Irina Artsimovitch, the study's lead author and an associate professor of microbiology at Ohio State . "Say a bacterium has 3,000 genes - NusG would regulate 2,900 of them." But somewhere along the evolutionary path, NusG was copied and physically changed. The result was a specialized transcription factor called RfaH. Unlike NusG, RfaH controls only a small portion of gene expression. But it happens to turn on those genes that give bacteria like E. coli and Y. pestis their ability to infect. The researchers say that this study likely marks the first successful attempt by a laboratory to determine the structure of RfaH. They used special X-ray techniques to study and describe RfaH proteins that they had extracted from E. coli. They found that while about two-thirds of RfaH's structure closely resembles the structure of NusG, the remaining one-third looked dramatically different. It's this latter third that appears to be the portion of the protein responsible for controlling the genes that make E. coli infectious. "In contrast to NusG, which is always active, RfaH is usually inactive, because the part of the protein that is needed to activate gene expression is typically masked," Svetlov said. It's only when RfaH finds the appropriate target sequence on a bacterium's DNA that this small portion of the protein is unmasked and can then turn on a select group of genes. These genes let disease-causing bacteria infect their host while at the same time protecting the bacteria from the host's immune defenses. "E. coli seems to prevent RfaH from acting unless the microorganism absolutely needs it," Artsimovitch said. That's because bacteria like E. coli are caught in a delicate balancing act. With too little RfaH, bacteria grow too slowly. But too much RfaH, and they will die. While RfaH's control over gene expression is limited, it seems that its structure lets it control key sequences of the genome during transcription, the process of transferring genetic information inside a cell and one of the first steps of gene expression. "Making RfaH work only at specific sites is, in a sense, a genius way to prevent it from interfering with NusG," Artsimovitch said. "It seems that the only genes that RfaH can't regulate are those controlled by NusG." Bacteria can survive without RfaH, but not without NusG. Yet without RfaH, bacteria lose the ability to infect. In previous laboratory experiments, the researchers found that pathogens lacking RfaH grow at much slower rates. "Cells usually don't die when RfaH use changes," Svetlov said. "Rather, bacteria seem to manipulate the protein, to play around with it. Too much RfaH will kill a cell, while too little would prevent it from infecting any living being. "We think that RfaH is responsible for more than making a microbe infectious," he continued. "Actually seeing what happens at the molecular level will help us figure out what else this protein regulates." Svetlov and Artsimovitch conducted the study with Georgy Belogurov, a postdoctoral research associate in microbiology at Ohio State, and with researchers from the University of Alabama at Birmingham, the Howard Hughes Medical Institute and the University of Texas Southwestern Medical Center in Dallas. Ohio State University | |||||||||||||||||||||
|
Related Gene Expression Current Events and Gene Expression News Articles Early-stage gene transcription creates access to DNA A gene contained in laboratory yeast has helped an international team of researchers uncover new findings about the process by which protein molecules bind to control sequences in genes in order to initiate gene expression, according to findings reported in the journal Nature. Short RNAs show a long history MicroRNAs, the tiny molecules that fine-tune gene expression, were first discovered in 1993. But it turns out they've been around for a billion years. Caltech scientists find cells coordinate gene activity with FM bursts How a cell achieves the coordinated control of a number of genes at the same time, a process that's necessary for it to regulate its own behavior and development, has long puzzled scientists. Conaway Lab Identifies Novel Mechanism for Regulation of Gene Expression The Stowers Institute's Conaway Lab has demonstrated that an enzyme called Uch37 is kept in check when it is part of a human chromatin remodeling complex, INO80. The results were published in today's issue of Molecular Cell. Probiotic bacteria can induce monocyte-derived dendritic cells maturation? Probiotic bacteria are widely used to relieve the symptoms of many disorders such as inflammatory bowel syndrome, diarrhea, and allergies. Probiotic mixtures have also been found to reduce the symptoms of diarrhea. International TGen-led team finds link between brain protein and Alzheimer's disease Investigators at the Translational Genomics Research Institute (TGen) today announced a link between the brain protein KIBRA and Alzheimer's disease, a discovery that could lead to promising new treatments for this memory-robbing disorder. Wistar researchers invigorate 'exhausted' immune cells In battles against chronic infections, the body's key immune cells often become exhausted and ineffective. Researchers at The Wistar Institute have found a way to restore vigor to these killer T cells by blocking a key receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C, and cancer. COPD? Eat your veggies You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might. Immaturity of the brain may cause schizophrenia The underdevelopment of a specific region in the brain may lead to schizophrenia in individuals. According to research published today in BioMed Central's open access journal Molecular Brain, dentate gyrus, which is located in the hippocampus in the brain and thought to be responsible for working memory and mood regulation, remained immature in an animal model of schizophrenia. DNA 'tattoos' link adult, daughter stem cells in planarians Unlike some parents, adult stem cells don't seem to mind when their daughters get a tattoo. In fact, they're willing to pass them along. More Gene Expression Current Events and Gene Expression News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||